CytoDyn (CYDY) Assets (2011 - 2026)
CytoDyn (CYDY) reported Assets of $19.05 million for fiscal Q1 2027 (quarter ended Aug 31, 2026), up 41.3% from $13.48 million a year earlier and up 36.4% from the prior quarter.
Powered by 
Analysis
CytoDyn (CYDY) Assets (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended May 31, 2026), CytoDyn posted Assets of $13.97 million, down 22.6% from FY2025.
- Assets has a five-year compound annual growth rate of -36.2% (FY2021 to FY2026).
- By fiscal year, Assets came in at $18.05 million in FY2025 (+62.1%), $11.14 million in FY2024 (-1.4%), $11.29 million in FY2023 (-61.3%) and $29.19 million in FY2022 (-77.9%).
- The fiscal Q1 2027 figure ranks as the highest quarterly Assets since fiscal Q3 2025.
- Year over year, Assets gained in four of the last eight quarters, with growth averaging 28.5%.
- The high point for year-over-year Assets in five years was fiscal Q2 2025 (growth of 169.2%); the low point was fiscal Q2 2023 (a decline of 93.2%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $13.97 million (Q4 2026), $18.5 million (Q3 2026) and $8.94 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,167.69 Bn | 1,136.27 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 648.01 Bn | 567.87 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 503.52 Bn | 476.63 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 367.68 Bn | 322.06 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 303.32 Bn | 267.31 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 269.17 Bn | 242.86 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 242.30 Bn | 197.70 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 195.24 Bn | 169.44 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 172.59 Bn | 119.24 Bn | 10.94 Bn | 201.13 Bn |
| 10 | CytoDyn | 331.73 Mn | 282.89 Mn | - | 19.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 19.05 Mn |
| May 31, 2026 | 13.97 Mn |
| Feb 28, 2026 | 18.50 Mn |
| Nov 30, 2025 | 8.94 Mn |
| Aug 31, 2025 | 13.48 Mn |
| May 31, 2025 | 18.05 Mn |
| Feb 28, 2025 | 21.19 Mn |
| Nov 30, 2024 | 24.88 Mn |
| Aug 31, 2024 | 28.02 Mn |
| May 31, 2024 | 11.14 Mn |
| Feb 29, 2024 | 10.27 Mn |
| Nov 30, 2023 | 9.24 Mn |
| Aug 31, 2023 | 12.41 Mn |
| May 31, 2023 | 11.29 Mn |
| Feb 28, 2023 | 14.64 Mn |
| Nov 30, 2022 | 7.07 Mn |
| Aug 31, 2022 | 28.39 Mn |
| May 31, 2022 | 29.19 Mn |
| Feb 28, 2022 | 94.08 Mn |
| Nov 30, 2021 | 103.70 Mn |
API Access
CytoDyn Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=CYDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "CYDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=CYDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();